Gene · 8030
Papers1,913
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,913
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations. | Nat Cancer | 2023 | 37743366 | PubTator, text mining | PubMed |
| Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China. | Thorac Cancer | 2023 | 37718634 | PubTator, text mining | PubMed |
| Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial. | Cancer Discov | 2023 | 37707791 | PubTator, text mining | PubMed |
| aenmd: annotating escape from nonsense-mediated decay for transcripts with protein-truncating variants. | Bioinformatics | 2023 | 37688563 | PubTator, text mining | PubMed |
| The Influence of Race/Ethnicity on the Transcriptomic Landscape of Uterine Fibroids. | Int J Mol Sci | 2023 | 37686244 | PubTator, text mining | PubMed |
| Targeted therapies in non-small cell lung cancer: present and future. | Fac Rev | 2023 | 37675274 | PubTator, text mining | PubMed |
| Physiopathological role of extracellular vesicles in alloimmunity and kidney transplantation and their use as biomarkers. | Front Immunol | 2023 | 37662919 | PubTator, text mining | PubMed |
| Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application. | J Exp Clin Cancer Res | 2023 | 37658402 | PubTator, text mining | PubMed |
| The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells. | Mol Cancer | 2023 | 37649123 | PubTator, text mining | PubMed |
| Clinical and Pathological Characteristics of Patients With Papillary Thyroid Carcinoma Coexisting With Hashimoto's Thyroiditis: A Retrospective Cohort Study. | Cancer Control | 2023 | 37643366 | PubTator, text mining | PubMed |
| Severe problem of macrolides resistance to common pathogens in China. | Front Cell Infect Microbiol | 2023 | 37637457 | PubTator, text mining | PubMed |
| TCAF2 in Pericytes Promotes Colorectal Cancer Liver Metastasis via Inhibiting Cold-Sensing TRPM8 Channel. | Adv Sci (Weinh) | 2023 | 37635201 | PubTator, text mining | PubMed |
| Sustainable Electropolymerization of Zingerone and Its C2 Symmetric Dimer for Amperometric Biosensor Films. | Molecules | 2023 | 37630267 | PubTator, text mining | PubMed |
| RET-Altered Cancers-A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity. | Cancers (Basel) | 2023 | 37627175 | PubTator, text mining | PubMed |
| Planar pentacoordinate s-block metals. | Chem Sci | 2023 | 37621437 | PubTator, text mining | PubMed |
| Convergent activation of two-pore channels mediated by the NAADP-binding proteins JPT2 and LSM12. | Sci Signal | 2023 | 37607218 | PubTator, text mining | PubMed |
| Translation-coupled mRNA quality control mechanisms. | EMBO J | 2023 | 37605642 | PubTator, text mining | PubMed |
| The efficacy and safety of selective RET inhibitors in RET fusion-positive non-small cell lung cancer: a meta-analysis. | Invest New Drugs | 2023 | 37603207 | PubTator, text mining | PubMed |
| Advances in transcriptomics and proteomics in differentiated thyroid cancer: An updated perspective (Review). | Oncol Lett | 2023 | 37600346 | PubTator, text mining | PubMed |
| Targeted treatments after chemoradiotherapy failure in a patient with relapsed, advanced non‑small cell lung cancer with on‑therapy circulating tumor biomarker monitoring: A case report. | Oncol Lett | 2023 | 37600327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8030/papers?page=10